Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2025-01-03T10:31:37.704Z Has data issue: false hasContentIssue false

1 - Battle Blood

Published online by Cambridge University Press:  13 June 2022

By
Claire Roddie
Edited by
Iosifina Foskolou  and
Martin Jones
Iosifina Foskolou
Affiliation:
University of Cambridge
Martin Jones
Affiliation:
University of Cambridge
Get access

Summary

A new therapy that uses the patient's own blood to cure blood cancers (leukaemias) is the focus of this chapter. The history of its detection and diagnosis is related, along with the long and arduous search for effective treatment, arriving at successful employment of bone marrow transplantation in the later twentieth century. More recent developments in chemotherapy are reviewed, leading to a contemporary account of the encouraging progress with T-cell therapies.

Keywords

leukaemiacancerimmune systemT-cellsmedicineclinical trials
Type
Chapter
Information
Blood , pp. 6 - 17
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Belloc, H. (1907) ‘Henry King’. In Cautionary Tales for Children. London: Duckworth.Google Scholar
Bennett, J. H. (1845) ‘Case 2, case of hypertrophy of the spleen and liver, in which death took place from suppuration of the blood’. Edinburgh Medical and Surgical Journal 64, 413–423.Google Scholar
Chavez, J. C., Bachmeier, C., and Kharfan-Dabaja, M. A. (2019) ‘CAR T-cell therapy for B-cell lymphomas: Clinical trial results of available products’. Theoretical Advances in Hematology 10, 2040620719841581.Google Scholar
Dausset, J. (1958) ‘Iso-leuco-anticorps’. Acta Haematology 20, 156–166.CrossRefGoogle Scholar
Eshhar, Z., Waks, T., Gross, G., and Schindler, D. G. (1993) ‘Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ or ζ subunits of the immunoglobulin and T-cell receptors’. Proceedings of the National Academy of Sciences 90, 720–724CrossRefGoogle ScholarPubMed
Farber, S. (1937) The Post-mortem Examination. Springfield, IL: C. C.Thomas.Google Scholar
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F. Jr., and Wolff, J. A. (1948) ‘Temporary remissions in acute leukaemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin)’. New England Journal of Medicine 238, 787–793.CrossRefGoogle Scholar
Fraietta, J. A., Lacey, S. F., Orlando, E. J., Pruteanu-Malinici, I., Gohil, M. et al. (2018) ‘Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia’. Nature Medicine 24(5), 563–571.CrossRefGoogle ScholarPubMed
Friedmann-Morvinski, D., Bendavid, A., Waks, T., Schindler, D., and Eshhar, Z. (2005) ‘Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation’. Blood 105, 3087–3093.Google Scholar
Grupp, S. A., Kalos, M., Barrett, D. Aplenc, R., Porter, D. L. et al. (2013) ‘Chimeric antigen receptor-modified T cells for acute lymphoid leukemia’. New England Journal of Medicine 368, 1509–1518.Google Scholar
Mathé, G., Jammet, H., Pendic, B., Schwarzenberg, L., Duplan, J. F. et al. (1959) ‘Transfusions et greffes de moelle osseuse homologue chez des humains irradiés à haute dose accidentellement’. Revue Française d’Études Cliniques et Biologiques 4(3), 226–238.Google Scholar
Mukherjee, S. (2010) The Emperor of All Maladies. New York: Scribner.Google Scholar
Thomas, E. D., Lochte, H. L., Lu, W. C., and Ferrebee, J. W. (1957) ‘Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy’. The New England Journal of Medicine 257, 491–496.CrossRefGoogle ScholarPubMed
Thomas, E. D., Storb, R., Clift, R. A., Fefer, A., Johnson, L. et al. (1975) ‘Bone-marrow transplantation (second of two parts)’. New England Journal of Medicine 292, 895–902.CrossRefGoogle ScholarPubMed
Virchow, R. L. K. (1856) ‘Die Leukämie’. In Gesammelte Abhandlungen zur wissenschaftlichen Medizin. Frankfurt: Meidinger, pp. 190–212.Google Scholar
Wills, L. (1933) ‘The nature of the haemopoietic factor in Marmite’. Lancet 221, 1283–1285.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×